These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16648168)

  • 1. Flexibility in a drug transport accessory protein: molecular dynamics simulations of MexA.
    Vaccaro L; Koronakis V; Sansom MS
    Biophys J; 2006 Jul; 91(2):558-64. PubMed ID: 16648168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the periplasmic component of a bacterial drug efflux pump.
    Higgins MK; Bokma E; Koronakis E; Hughes C; Koronakis V
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):9994-9. PubMed ID: 15226509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring transmembrane allostery in the MexB: DB08385 variant as a promising inhibitor-like candidate against
    Bera A; Mukherjee S; Patra N
    Phys Chem Chem Phys; 2024 Jun; 26(24):17011-17027. PubMed ID: 38835320
    [No Abstract]   [Full Text] [Related]  

  • 4. Tracking membrane protein association in model membranes.
    Reffay M; Gambin Y; Benabdelhak H; Phan G; Taulier N; Ducruix A; Hodges RS; Urbach W
    PLoS One; 2009; 4(4):e5035. PubMed ID: 19337368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of interdomain interactions on the intradomain motions in yeast phosphoglycerate kinase: a molecular dynamics study.
    Balog E; Laberge M; Fidy J
    Biophys J; 2007 Mar; 92(5):1709-16. PubMed ID: 17158564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing functional motions of membrane transporters with molecular dynamics simulations.
    Shaikh SA; Li J; Enkavi G; Wen PC; Huang Z; Tajkhorshid E
    Biochemistry; 2013 Jan; 52(4):569-87. PubMed ID: 23298176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA.
    Cacciotto P; Basciu A; Oliva F; Malloci G; Zacharias M; Ruggerone P; Vargiu AV
    Comput Struct Biotechnol J; 2022; 20():252-260. PubMed ID: 35024097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL
    Liu WS; Li HG; Ding CH; Zhang HX; Wang RR; Li JQ
    Aging (Albany NY); 2021 Mar; 13(5):6258-6272. PubMed ID: 33678621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic export by MexB multidrug efflux transporter is allosterically controlled by a MexA-OprM chaperone-like complex.
    Glavier M; Puvanendran D; Salvador D; Decossas M; Phan G; Garnier C; Frezza E; Cece Q; Schoehn G; Picard M; Taveau JC; Daury L; Broutin I; Lambert O
    Nat Commun; 2020 Oct; 11(1):4948. PubMed ID: 33009415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Intact MexAB-OprM Efflux Pump: Focusing on the MexA-OprM Interface.
    López CA; Travers T; Pos KM; Zgurskaya HI; Gnanakaran S
    Sci Rep; 2017 Nov; 7(1):16521. PubMed ID: 29184094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
    Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on the Outer Membrane Factor OprM, the Forgotten Player from Efflux Pumps Assemblies.
    Phan G; Picard M; Broutin I
    Antibiotics (Basel); 2015 Nov; 4(4):544-66. PubMed ID: 27025640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripartite assembly of RND multidrug efflux pumps.
    Daury L; Orange F; Taveau JC; Verchère A; Monlezun L; Gounou C; Marreddy RK; Picard M; Broutin I; Pos KM; Lambert O
    Nat Commun; 2016 Feb; 7():10731. PubMed ID: 26867482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa.
    Dreier J; Ruggerone P
    Front Microbiol; 2015; 6():660. PubMed ID: 26217310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architecture and roles of periplasmic adaptor proteins in tripartite efflux assemblies.
    Symmons MF; Marshall RL; Bavro VN
    Front Microbiol; 2015; 6():513. PubMed ID: 26074901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of RND-type multidrug exporters.
    Yamaguchi A; Nakashima R; Sakurai K
    Front Microbiol; 2015; 6():327. PubMed ID: 25941524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of coupling drug transport reactions located in two different membranes.
    Zgurskaya HI; Weeks JW; Ntreh AT; Nickels LM; Wolloscheck D
    Front Microbiol; 2015; 6():100. PubMed ID: 25759685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational study of correlated domain motions in the AcrB efflux transporter.
    Schulz R; Vargiu AV; Ruggerone P; Kleinekathöfer U
    Biomed Res Int; 2015; 2015():487298. PubMed ID: 25685792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the periplasmic adaptor protein from a major facilitator superfamily (MFS) multidrug efflux pump.
    Hinchliffe P; Greene NP; Paterson NG; Crow A; Hughes C; Koronakis V
    FEBS Lett; 2014 Aug; 588(17):3147-53. PubMed ID: 24996185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.